Consolidation chemotherapy after definite concurrent chemoradiation in patients with non-operable esophageal cancer: Is it useful?

被引:4
作者
Adenis, Antoine [1 ]
Castan, Florence [1 ]
Conroy, Thierry [2 ]
机构
[1] Inst Canc Montpellier, Montpellier, France
[2] Inst Cancerol Lorraine, Vandoeuvre Les Nancy, France
关键词
FLUOROURACIL; CISPLATIN; FOLFOX; TRIAL;
D O I
10.1016/j.radonc.2017.12.018
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:180 / 181
页数:2
相关论文
共 5 条
[1]   Health-related quality of life results from the PRODIGE 5/ACCORD 17 randomised trial of FOLFOX versus fluorouracil-cisplatin regimen in oesophageal cancer [J].
Bascoul-Mollevi, C. ;
Gourgou, S. ;
Galais, M-P. ;
Raoul, J-L. ;
Bouche, O. ;
Douillard, J-Y. ;
Adenis, A. ;
Etienne, P-L. ;
Juzyna, B. ;
Bedenne, L. ;
Conroy, T. .
EUROPEAN JOURNAL OF CANCER, 2017, 84 :239-249
[2]  
Chen Y, 2017, RADIOTHER ONCOL, V123, P483
[3]   Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial [J].
Conroy, Thierry ;
Galais, Marie-Pierre ;
Raoul, Jean-Luc ;
Bouche, Olivier ;
Gourgou-Bourgade, Sophie ;
Douillard, Jean-Yves ;
Etienne, Pierre-Luc ;
Boige, Valerie ;
Martel-Lafay, Isabelle ;
Michel, Pierre ;
Llacer-Moscardo, Carmen ;
Francois, Eric ;
Crehange, Gilles ;
Ben Abdelghani, Meher ;
Juzyna, Beata ;
Bedenne, Laurent ;
Adenis, Antoine .
LANCET ONCOLOGY, 2014, 15 (03) :305-314
[4]   COMBINED CHEMOTHERAPY AND RADIOTHERAPY COMPARED WITH RADIOTHERAPY ALONE IN PATIENTS WITH CANCER OF THE ESOPHAGUS [J].
HERSKOVIC, A ;
MARTZ, K ;
ALSARRAF, M ;
LEICHMAN, L ;
BRINDLE, J ;
VAITKEVICIUS, V ;
COOPER, J ;
BYHARDT, R ;
DAVIS, L ;
EMAMI, B .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (24) :1593-1598
[5]   Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up [J].
Lordick, F. ;
Mariette, C. ;
Haustermans, K. ;
Obermannova, R. ;
Arnold, D. .
ANNALS OF ONCOLOGY, 2016, 27 :v50-v57